Afuco™ Anti-Human IL34 ADCC Therapeutic Antibody, ADCC Enhanced

Anti-IL34 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The anti-IL-34 antibodies are used for treating myeloid pathogenic immunological diseases.
Supplier Creative Biolabs
Product # AFC-412CL
Pricing Inquiry
Host Human
Target IL34
Species Reactivity Human
Type ADCC enhanced antibody
Storage Store at –20 or -70°C upon receipt. Divide antibody into aliquots prior usage and avoid multiple freeze-thaw cycles.
Feedback